David K. Clawson

3.6k total citations · 1 hit paper
40 papers, 2.5k citations indexed

About

David K. Clawson is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, David K. Clawson has authored 40 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Organic Chemistry and 11 papers in Oncology. Recurrent topics in David K. Clawson's work include Protein Kinase Regulation and GTPase Signaling (7 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Chemical Synthesis and Analysis (5 papers). David K. Clawson is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (7 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Chemical Synthesis and Analysis (5 papers). David K. Clawson collaborates with scholars based in United States and France. David K. Clawson's co-authors include Richard W. Schevitz, Nickolay Y. Chirgadze, Jean‐Pierre Wery, Steve Briggs, Faming Zhang, Lisa M. Churgay, Dennis P. Smith, John E. Hale, John M. Beals and Brigitte Schoner and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

David K. Clawson

40 papers receiving 2.4k citations

Hit Papers

Crystal structure of the obese protein Ieptin-E100 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David K. Clawson United States 23 1.2k 489 405 307 296 40 2.5k
Steve Briggs United States 17 776 0.7× 141 0.3× 390 1.0× 298 1.0× 259 0.9× 37 1.7k
John P. Mayer United States 28 1.4k 1.2× 625 1.3× 471 1.2× 261 0.9× 375 1.3× 73 3.2k
Daniel F. Wyss United States 31 1.6k 1.4× 382 0.8× 131 0.3× 323 1.1× 71 0.2× 58 3.4k
Gunnar Lindeberg Sweden 30 1.4k 1.2× 632 1.3× 146 0.4× 346 1.1× 151 0.5× 89 2.7k
Frédéric Becq France 38 1.8k 1.5× 450 0.9× 139 0.3× 224 0.7× 252 0.9× 134 3.9k
Christine A. Collins United States 29 1.1k 0.9× 160 0.3× 234 0.6× 92 0.3× 217 0.7× 62 3.3k
Thomas E. Hughes United States 26 1.3k 1.2× 172 0.4× 121 0.3× 1.0k 3.3× 94 0.3× 51 3.6k
María C. Ochoa Spain 36 939 0.8× 560 1.1× 65 0.2× 1.7k 5.7× 113 0.4× 116 4.3k
Daniel Lundell United States 27 1.3k 1.1× 233 0.5× 64 0.2× 923 3.0× 74 0.3× 57 3.4k
Masataka Harada Japan 16 822 0.7× 170 0.3× 57 0.1× 842 2.7× 83 0.3× 45 2.2k

Countries citing papers authored by David K. Clawson

Since Specialization
Citations

This map shows the geographic impact of David K. Clawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David K. Clawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David K. Clawson more than expected).

Fields of papers citing papers by David K. Clawson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David K. Clawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David K. Clawson. The network helps show where David K. Clawson may publish in the future.

Co-authorship network of co-authors of David K. Clawson

This figure shows the co-authorship network connecting the top 25 collaborators of David K. Clawson. A scholar is included among the top collaborators of David K. Clawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David K. Clawson. David K. Clawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benschop, Robert J., Chi-Kin Chow, Yu Tian, et al.. (2019). Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. mAbs. 11(6). 1175–1190. 34 indexed citations
2.
Meng, Yilin, Cen Gao, David K. Clawson, et al.. (2018). Predicting the Conformational Variability of Abl Tyrosine Kinase using Molecular Dynamics Simulations and Markov State Models. Journal of Chemical Theory and Computation. 14(5). 2721–2732. 44 indexed citations
5.
Savkur, Rajesh S., Kelli Bramlett, David K. Clawson, & Thomas P. Burris. (2004). Pharmacology of Nuclear Receptor–Coregulator Recognition. Vitamins and hormones. 68. 145–183. 22 indexed citations
6.
Clawson, David K., Douglas W. Jackson, & Daniel J. Ostergaard. (2001). Itʼs Past Time to Reform the Musculoskeletal Curriculum. Academic Medicine. 76(7). 709–710. 73 indexed citations
8.
Jin, Lei, Steve Briggs, Srinivasan Chandrasekhar, et al.. (2000). Crystal Structure of Human Parathyroid Hormone 1–34 at 0.9-Å Resolution. Journal of Biological Chemistry. 275(35). 27238–27244. 85 indexed citations
9.
Wiley, Michael R., Leonard C. Weir, Nickolay Y. Chirgadze, et al.. (1999). The design of potent, selective, non-covalent, peptide thrombin inhibitors utilizing imidazole as a S1 binding element. Bioorganic & Medicinal Chemistry Letters. 9(18). 2767–2772. 23 indexed citations
10.
Sall, Daniel J., Steve Briggs, Nickolay Y. Chirgadze, et al.. (1998). Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 2. Exploring interactions at the proximal (S2) binding site. Bioorganic & Medicinal Chemistry Letters. 8(18). 2527–2532. 8 indexed citations
11.
Barnard, Darlene, Bruce Diaz, David K. Clawson, & Mark S. Marshall. (1998). Oncogenes, growth factors and phorbol esters regulate Raf-1 through common mechanisms. Oncogene. 17(12). 1539–1547. 69 indexed citations
12.
Zhang, Faming, John M. Beals, Steve Briggs, et al.. (1997). Crystal structure of the obese protein Ieptin-E100. Nature. 387(6629). 206–209. 541 indexed citations breakdown →
13.
Schevitz, Richard W., Nicholas J. Bach, Nickolay Y. Chirgadze, et al.. (1995). Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2. Nature Structural & Molecular Biology. 2(6). 458–465. 188 indexed citations
14.
Wery, Jean‐Pierre, Richard W. Schevitz, David K. Clawson, et al.. (1991). Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 Å resolution. Nature. 352(6330). 79–82. 182 indexed citations
15.
Rabideau, Peter W., Raj K. Dhar, David K. Clawson, & Zheng-Yun J. Zhan. (1991). Silicon Mediated Alkylations in the 9,10-Dihydroanthracene System: a Convenient Synthesis of 9,9-Dialkyl-9,10- Dihydroanthracenes.. Tetrahedron Letters. 32(32). 3969–3972. 2 indexed citations
16.
Clawson, David K.. (1990). The education of the physician. Academic Medicine. 65(2). 84–8. 7 indexed citations
17.
Jones, N.D., et al.. (1987). APOCALYPSEnow: update on automated protein crystallization using the new ACA vapor diffusion plate. Acta Crystallographica Section A Foundations of Crystallography. 43(a1). C275–C275. 2 indexed citations
18.
Weiler, Philip G. & David K. Clawson. (1979). Medical schools and public health departments. Academic Medicine. 54(3). 217–23. 4 indexed citations
19.
Lippert, Frederick G., et al.. (1975). A psychomotor skills course for orthopaedic residents. Academic Medicine. 50(10). 982–3. 29 indexed citations
20.
Clawson, David K., et al.. (1971). Functional assessment of the rheumatoid hand.. PubMed. 77. 203–10. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026